The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2026
Filed:
Apr. 23, 2021
Applicant:
Guangzhou Kangrui Biological Pharmaceutical Technology Co., Ltd., Guangzhou, CN;
Inventors:
Guangxi Zang, Guangzhou, CN;
Rui Hou, Guangzhou, CN;
Assignee:
Lan Tech Limited, Tortola, VG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 31/506 (2006.01); A61K 47/02 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); A61P 17/00 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); A61P 27/10 (2006.01); A61P 27/12 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/10 (2013.01); A61K 31/506 (2013.01); A61K 47/02 (2013.01); A61K 47/34 (2013.01); A61P 27/02 (2018.01);
Abstract
A pharmaceutical composition for ophthalmic dosing or administration is disclosed, comprising (i) a compound of Formula (I) or an isotopic variant, tautomer, pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) at least one pharmaceutically acceptable excipient. The pharmaceutical composition is formulated as a suspension. The composition may be used to treat ophthalmic disorders and diseases caused by abnormal proliferation of angiogenesis.